U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836271) titled 'Cleaning the Biopsy Needle in TRUS Bx' on Jan. 30.
Brief Summary: Prostate cancer(PCa) is the second most common cancer diagnosed in men. Clinical suspicion of PCa is mentioned in patients with digital rectal examination findings and elevated serum PSA. Despite all the advances in radiological imaging methods, the gold standard method in the diagnosis of the disease is systematic prostate biopsy performed under the guidance of transrectal ultrasonography, which is an invasive procedure.
In TRUS-guided transrectal prostate biopsy, bacteriuria may develop as a result of the rectum flora being injected into the urinary system through ...